Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Dr Reddy's declines 3% after China's regulator bans import of ADHD drug

Atomoxetine is used for treating attention deficit hyperactivity disorder (ADHD) in adults and children over six years.

By: business-standard.com

Sep 02 2024
0
0 Views

Dr Reddy's declines 3% after China's regulator bans import of ADHD drug

Dr Reddy's declines 3% after China's regulator bans import of ADHD drug

Related

Hero MotoCorp Ltd gains for third straight session

Bajaj Finserv Ltd soars 3.29%

Coal India records decline in operational performance in Aug'24

Sandur Manganese gets environment clearance for iron ore production from Ramghad Mine

How to trade newly crowned Navratnas: RailTel, SJVN, NHPC

Naraingarh Sugar Mills reports standalone net loss of Rs 12.61 crore in the June 2024 quarter

Tata Steel Ltd eases for fifth straight session

Barometers trade with minor gains; European mkt decline

NBCC (India) wins orders worth 183 crore

Dr Reddy's declines 3% after China's regulator bans import of ADHD drug

The Anup Eng stock rises 4%, hits 52-week high on pact with Graham Corp

Coal India production slides 12% YoY to 46.1 MT in Aug'24

Hero MotoCorp Ltd gains for third straight session